16-75204904-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001025200.4(CTRB2):c.499A>T(p.Asn167Tyr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001025200.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 6AN: 105946Hom.: 0 Cov.: 13 FAILED QC
GnomAD3 exomes AF: 0.000266 AC: 28AN: 105142Hom.: 1 AF XY: 0.000314 AC XY: 17AN XY: 54224
GnomAD4 exome AF: 0.0000896 AC: 85AN: 949094Hom.: 2 Cov.: 13 AF XY: 0.0000929 AC XY: 44AN XY: 473732
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000566 AC: 6AN: 106026Hom.: 0 Cov.: 13 AF XY: 0.0000604 AC XY: 3AN XY: 49656
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.499A>T (p.N167Y) alteration is located in exon 6 (coding exon 6) of the CTRB2 gene. This alteration results from a A to T substitution at nucleotide position 499, causing the asparagine (N) at amino acid position 167 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at